| The DNA methylation in neurological diseases S Younesian, AM Yousefi, M Momeny, SH Ghaffari, D Bashash Cells 11 (21), 3439, 2022 | 35 | 2022 |
| Cyclins and cyclin-dependent kinases: From biology to tumorigenesis and therapeutic opportunities M Zabihi, R Lotfi, AM Yousefi, D Bashash Journal of cancer research and clinical oncology 149 (4), 1585-1606, 2023 | 15 | 2023 |
| ZnO/CNT@Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment AM Yousefi, A Safaroghli-Azar, Z Fakhroueian, D Bashash Artificial Cells, Nanomedicine, and Biotechnology 48 (1), 735-745, 2020 | 14 | 2020 |
| CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges ABS Khorasani, AM Yousefi, D Bashash International Immunopharmacology 110, 109041, 2022 | 12 | 2022 |
| Predictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: A systematic review and meta-analysis M Noori, AM Yousefi, MR Zali, D Bashash Frontiers in Oncology 12, 1021859, 2022 | 11 | 2022 |
| Anti‐leukemic effect of PI3K inhibition on chronic myeloid leukemia (CML) cells: shedding new light on the mitigating effect of c‐Myc and autophagy on BKM120 cytotoxicity R Shiri Heris, A Safaroghli‐Azar, AM Yousefi, M Hamidpour, D Bashash Cell Biology International 44 (5), 1212-1223, 2020 | 10 | 2020 |
| Noncoding RNAs in diagnosis and prognosis of graft‐versus‐host disease (GVHD) MK Vajari, S Moradinasab, AM Yousefi, D Bashash Journal of Cellular Physiology 237 (9), 3480-3495, 2022 | 7 | 2022 |
| Abrogation of histone deacetylases (HDACs) decreases survival of chronic myeloid leukemia cells: New insight into attenuating effects of the PI3K/c‐Myc axis on panobinostat … S Zehtabcheh, AM Yousefi, S Salari, M Safa, M Momeny, SH Ghaffari, ... Cell Biology International 45 (5), 1111-1121, 2021 | 4 | 2021 |
| An overview of long noncoding RNAs: Biology, functions, therapeutics, analysis methods, and bioinformatics tools F Jafari‐Raddani, Z Davoodi‐Moghaddam, AM Yousefi, SH Ghaffari, ... Cell Biochemistry and Function 40 (8), 800-825, 2022 | 3 | 2022 |
| Application of ZnO/CNT@ Fe3O4 nanocomposite in amplifying the anti-leukemic effects of Imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia AM Yousefi, A Safaroghli-Azar, A Pourbagheri-Sigaroodi, Z Fakhroueian, ... Biomedical Materials 16 (3), 035029, 2021 | 3 | 2021 |
| ZnO Q-dots-induced apoptosis was coupled with the induction of PPARγ in acute promyelocytic leukemia cells; proposing a novel application of nanoparticles in combination with … S Esmaeili, A Pourbagheri-Sigaroodi, AM Yousefi, Z Fakhroueian, ... Journal of Cluster Science, 1-13, 2021 | 3 | 2021 |
| Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment N Zamani-Moghaddam, FS Mousavi, S Esmaeili, AM Yousefi, ... Cancer Treatment and Research Communications 26, 100284, 2021 | 3 | 2021 |
| Inhibition of Cyclin-dependent Kinase (CDK) decreased survival of NB4 leukemic cells: proposing a p53-independent sensitivity of leukemic cells to multi-CDKs inhibitor AT7519 A Pourbagheri-Sigaroodi, A Safaroghli-Azar, M Shanaki, AM Yousefi, ... Iranian Journal of Pharmaceutical Research: IJPR 19 (3), 144, 2020 | 3 | 2020 |
| The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies B Kashani, Z Zandi, A Pourbagheri‑Sigaroodi, AM Yousefi, SH Ghaffari, ... Expert Review of Anticancer Therapy, 1-20, 2024 | 1 | 2024 |
| C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cells S Zehtabcheh, AM Yousefi, M Momeny, D Bashash Molecular Biology Reports 50 (12), 10157-10167, 2023 | 1 | 2023 |
| Anticancer Effects of ZnO/CNT@ Fe3O4 in AML-Derived KG1 Cells: Shedding Light on Promising Potential of Metal Nanoparticles in Acute Leukemia AM Yousefi, A Pourbagheri-Sigaroodi, Z Fakhroueian, S Salari, K Fateh, ... International Journal of Hematology-Oncology and Stem Cell Research 16 (3), 140, 2022 | 1 | 2022 |
| The Superior Cytotoxicity of Dual Targeting of BCR/ABL and PI3K in K562 Cells: Proposing a Novel Therapeutic Potential for the Treatment of CML R Shiri Heris, A Pourbagheri-Sigaroodi, AM Yousefi, D Bashash Indian Journal of Hematology and Blood Transfusion 38 (1), 51-60, 2022 | 1 | 2022 |
| Inhibition of PI3K/AKT signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity SC Khameneh, S Sari, S Razi, AM Yousefi, D Bashash Molecular Biology Reports 51 (1), 420, 2024 | | 2024 |
| The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets R Taheri, Y Mokhtari, AM Yousefi, D Bashash Cell Biology International, 2024 | | 2024 |
| Inhibition of PI3K Signaling Intensified the Antileukemic Effects of Pioglitazone: New Insight into the Application of PPARγ Stimulators in Acute Lymphoblastic Leukemia Y Mokhtari, AM Yousefi, D Bashash Indian Journal of Hematology and Blood Transfusion 39 (4), 546-556, 2023 | | 2023 |
